BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33224826)

  • 1. Comparison between surgery plus radiotherapy and radiotherapy alone in treating breast cancer patients with ipsilateral supraclavicular lymph node metastasis.
    Sun XF; Wang YJ; Huang T; Niu LJ; Zhang Q; Liu ZZ
    Gland Surg; 2020 Oct; 9(5):1513-1520. PubMed ID: 33224826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Role of Supraclavicular lymph node dissection in Breast Cancer Patients with Synchronous Ipsilateral Supraclavicular Lymph Node Metastasis].
    Zhang W; Qi XM; Chen AX; Zhang P; Cao XC; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):374-379. PubMed ID: 28535656
    [No Abstract]   [Full Text] [Related]  

  • 3. The value of radiotherapy in breast cancer patients with isolated ipsilateral supraclavicular lymph node metastasis without distant metastases at diagnosis: a retrospective analysis of Chinese patients.
    Wu SG; Sun JY; Zhou J; Li FY; Lin Q; Lin HX; He ZY
    Onco Targets Ther; 2014; 7():281-8. PubMed ID: 24627640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supraclavicular lymph node dissection with radiotherapy versus radiotherapy alone for operable breast cancer with synchronous ipsilateral supraclavicular lymph node metastases: a real-world cohort study.
    Ai X; Wang M; Li J; Hu Y; Hou L; Zheng X; Yan Y; Pan Q; Jin Y; Liu W; Tan X; Tian Y; Zhang Y; Tang P; Jiang J
    Gland Surg; 2020 Apr; 9(2):329-341. PubMed ID: 32420257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Survival Outcomes Among Patients With Breast Cancer With Distant vs Ipsilateral Supraclavicular Lymph Node Metastases.
    Pan H; Wang H; Qian M; Mao X; Shi G; Ma G; Yu M; Xie H; Ling L; Ding Q; Zhang K; Wang S; Zhou W
    JAMA Netw Open; 2021 Mar; 4(3):e211809. PubMed ID: 33724394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of supraclavicular surgery plus radiotherapy versus radiotherapy alone in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis: A multicenter retrospective study.
    Song YC; Kong J; Li N; Liu XL; Li XH; Zhu LY; Wang YW; Fang H; Jing H; Tang Y; Li YX; Wang XH; Zhang J; Wang SL
    Radiother Oncol; 2023 Jun; 183():109639. PubMed ID: 36990395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of different local treatments in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis.
    Chang XZ; Yin J; Sun J; Zhang XH; Cao XC
    J Cancer Res Ther; 2013 Nov; 9 Suppl():S158-61. PubMed ID: 24516053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of surgery on locoregional treatment of patients with breast cancer newly diagnosed with ipsilateral supraclavicular lymph node metastasis.
    Liu BW; Chen LX; Ma K; Chi JR; Yang ZJ; Yu Y; Cao XC
    J Cancer Res Ther; 2022 Apr; 18(2):496-502. PubMed ID: 35645120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-center cross-sectional investigation of the diagnosis and treatment of breast cancer with synchronous ipsilateral supraclavicular lymph node metastases based on the CSBrs-009.
    Ai X; Sun P; Wang M; Tang P; Liu J; Jiang J
    Clin Transl Oncol; 2023 May; 25(5):1482-1487. PubMed ID: 36611099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of aggressive locoregional surgery in treatment strategies for ipsilateral supraclavicular lymph node metastasis of breast cancer: a real-world cohort study.
    Feng K; Xing Z; Dai Q; Cheng H; Wang X
    Front Mol Biosci; 2023; 10():1248410. PubMed ID: 37916188
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
    Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
    [No Abstract]   [Full Text] [Related]  

  • 12. A retrospective study of metachronous and synchronous ipsilateral supraclavicular lymph node metastases in breast cancer patients.
    Fan Y; Xu B; Liao Y; Yao S; Sun Y
    Breast; 2010 Oct; 19(5):365-9. PubMed ID: 20399657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the effect of ipsilateral supraclavicular lymph node metastasis on the prognosis of N3 breast cancer].
    Nilupai A; Wang JY; Li Q; Zhang P; Ma F; Yuan P; Luo Y; Cai RG; Fan Y; Li Q; Chen SS; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1069-1075. PubMed ID: 34695897
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined Therapy Can Improve the Outcomes of Breast Cancer with Isolated Supraclavicular Lymph Node Involvement.
    Ma T; Mao Y; Wang H
    Cancer Manag Res; 2020; 12():11857-11869. PubMed ID: 33239916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
    Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.
    Setton J; Cody H; Tan L; Morrow M; Hudis C; Catalano J; McCormick B; Powell S; Ho A
    Cancer; 2012 Apr; 118(8):1994-2003. PubMed ID: 21882186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical Lymph Node Involvement above the Supraclavicular Fossa in Breast Cancer: Comparison with Stage IIIC (KROG 18-02).
    Kim JS; Kim K; Shin KH; Kim JH; Ahn SD; Kim SS; Kim YB; Chang JS; Choi DH; Park W; Kim TH; Chun M; Cha J; Kim JH; Lee DS; Lee SY; Park HJ
    J Breast Cancer; 2020 Apr; 23(2):194-204. PubMed ID: 32395378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a Three-Dimensional Reconstruction System in Breast Cancer with Ipsilateral Supraclavicular Lymph Node Metastasis: A Case Series.
    Zhao P; Zou Q; Yuan L; Li L; Chen Q; Ouyang D; Yi W
    Breast Care (Basel); 2019 Jun; 14(3):176-179. PubMed ID: 31316317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
    Krag DN; Anderson SJ; Julian TB; Brown AM; Harlow SP; Costantino JP; Ashikaga T; Weaver DL; Mamounas EP; Jalovec LM; Frazier TG; Noyes RD; Robidoux A; Scarth HM; Wolmark N
    Lancet Oncol; 2010 Oct; 11(10):927-33. PubMed ID: 20863759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective multicenter study of combined treatment with chemotherapy and radiotherapy in breast cancer women with the rare clinical scenario of ipsilateral supraclavicular node recurrence without distant metastases.
    Pergolizzi S; Adamo V; Russi E; Santacaterina A; Maisano R; Numico G; Palazzolo C; FerraĆ¹ F; Settineri N; Altavilla G; Girlando A; Spadaro P; Cascinu S
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):25-32. PubMed ID: 16446058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.